Our Team

Co-Director

Kelly is a Research Fellow in Sustainable Development at the University of Exeter, with over twenty years’ experience of working across a variety of academic disciplines, science communication and project management. Her research is very applied, using systems thinking and public engagement methods to develop pragmatic solutions for addressing the complex issues of pharmaceutical pollution and antimicrobial resistance in aquatic environments.

Co-Director

Charles is a Professor of Environmental Biology at the University of Exeter and an internationally leading environmental scientist and ecotoxicologist with 35 years’ experience in this field. His research spans ecotoxicology, molecular systems biology, sustainable aquaculture, aquatic animal health, and conservation, with a strong emphasis on integrated whole animal physiology and the application of genomic and genetic tools for understanding organism function.

Charles works internationally with many government, industry and NGO stakeholders and has contributed to many reports and articles aimed at government, industry and the wider public, covering a broad range of environmental issues such as endocrine disruption, nanotoxicology, genomics and conservation. He has received various awards including the Fisheries Society of the British Isles Beverton Medal (2012), the Founders Award from the Society of Environmental Toxicology and Chemistry (2015), and the Marsh Award for Marine and Freshwater Conservation (2022, Zoological Society of London). He has published over 350 research papers/reviews and was named among the top 1% most highly cited researchers in the world (Clarivate 2021).

Lead for Working Group 1 —
Population health, awareness and behaviour

Hayden is the Lead for the Population Health and Digital Health Evaluation Teams, and Associate Director, at York Health Economics Consortium. He works on a range of projects from individual pharmaceuticals to wider public health initiatives including work for the NHS, NICE, pharmaceutical and medtech companies.

Hayden was previously the joint lead for the economic methodological unit (EMU) responsible for providing health economic advice to NICE’s public health advisory committees, and worked as a health economist at Pharmac, the government agency responsible for making decisions on which medicines, vaccines, hospital medical devices, cancer and haemophilia treatments are publicly funded in New Zealand.

Lead for Working Group 2 —
Pharmaceutical design, manufacture and licencing

Ross is a Senior Research Fellow at the University of Exeter. His research focuses on refining environmental risk assessment approaches to safeguard aquatic ecosystems from pollution and to facilitate the sustainable development of aquaculture. He employs molecular, ecotoxicological and ecological modelling and monitoring approaches to characterise and quantify the vulnerability of species, populations and assemblages to physical, chemical and (micro)biological factors.

Lead for Working Group 3 —
Healthcare decision making

Caroline is a Research Fellow at the University of Exeter. She is a highly experienced systematic reviewer with a background in conducting literature reviews to inform health policy and practice in the UK and internationally. Caroline has worked within health technology appraisal (HTA) for a number of years, working on behalf of both manufacturers and regulatory agencies. She is currently appraising health technology, highly specialised technology and medical device HTA submissions on behalf of the National Institute of Health and Care Excellence (NICE).

Lead for Working Group 4 —
Pharmacy sales and disposal

Minna is the Vice Chair of Sustainability at the Guild of Healthcare Pharmacists, Co-Founder of Pharmacy Declares and Co-Chair of European Association of Hospital Pharmacists Sustainability Working Group.

Lead for Working Group 5 —
Environmental monitoring and management

Lydia is a research associate in environmental science and One Health based at the Environmental Research Institute, University of the Highlands and Islands. Her research focuses on emerging contaminants and pharmaceuticals, environmental pollution, and sustainable healthcare. She is a coordinator of the One Health Breakthrough Partnership, working with cross-sector stakeholders to investigate pharmaceutical pollution and sustainable healthcare practices in Scotland.